1-(4-CHLOROQUINAZOLIN-2-YL)-N,N-DIMETHYLMETHANAMINE, 95%, 1g

2,3,4,5,6-Penta(9H-carbazol-9-yl)benzonitrile, 98%, 100mg

N,N'-Dimethyl-3,4,9,10-perylenetetracarboxylic Diimide>92.0%(N)5g

Matraces aforados clase B transparente, 500 ml, 19/26, 2 Unidad(es)

Methyl 4-(1H-imidazol-1-yl)benzoate, 95.0%, 25g

2-(4-tert-Butylphenyl)-5-(4-biphenyl)-1,3,4-oxadiazole, 95.0%, 1g

1-(2-methoxyethyl)-1H-pyrrole-2-carbaldehyde, 98.0%, 1g

tert-Butyl (2,3-dihydroxypropyl)carbamate, 95.0%, 25g

3-Bromo-2-chlorothiophene, 95.0%, 10g

4-{5-[1-(tert-Butoxycarbonyl)piperidin-4-yl]-1H-tetrazol-1-yl}benzoic acid, 250mg

3,3-Dimethylglutaric anhydride, 99.0%, 10g

Betamethasone disodium phosphate, 10g

(5E)-5-(4-hydroxybenzylidene)-2-mercapto-1,3-thiazol-4(5H)-one, 95.0%, 1g